Industry News
Malaria vaccine wins Gates Foundation grant
A carbohydrate-based malaria vaccine developed by Australian researchers has won a US$1 million grant from the Bill & Melinda Gates Foundation. [ + ]
QRxPharma gets target date for MoxDuo IR FDA approval
Pending approval by the FDA, QRxPharma's (ASX:QRX) MoxDuo IR could be given the go ahead for sale by June 25 2012. [ + ]
Prof Bruce McKellar to head international physics union
Australian Academy of Science Fellow Professor Bruce McKellar has been elected as the next President of the IUPAP.
[ + ]AusBiotech and PwC webcast gives update on the state of the nation's biotechnology sector
The latest in the series of webcasts that discuss the latest happenings in the sector with AusBiotech and the results of PricewaterhouseCoopers' (PwC) BioForum quarterly report is out now. [ + ]
Feature: New pathways for cancer therapy
Associate Professor Stuart Pitson has been delving into the world of sphingolipid-mediated cell signalling pathways, particularly their enticing possibilities in cancer treatment. [ + ]
Immuron submits IND for liver disease drug
Immuron (ASX:IMC) to commence phase IIb clinical trial for drug to treat fatty liver disease, including Nonalcoholic steatohepatitis (NASH). [ + ]
Alchemia to spin off oncology business
Alchemia (ASX:ACL) intends to create new wholly-owned oncology business to develop chemotherapy drug delivery technology, HyACT. [ + ]
Circadian to start phase I trials for cancer drug after receiving IND approval
Circadian (ASX:CIR) to initiate phase I trials after receiving investigational new drug status from the Food and Drug Administration for VGX-100 anti-cancer drug. [ + ]
Clinuvel’s Scenesse sees positive trial results
A phase II study of Clinuvel’s (ASX:CUV) photoprotective Scenesse shows it is effective and safe in treating the rare disorder, erythropoietic protoporphyria (EPP). [ + ]
New Commonwealth committee for government research investments
Prof Ian Chubb will chair a new Commonwealth committee to guide government research investment.
[ + ]Protein microarray uncovers malaria immunity
Researchers at the Walter and Eliza Hall institute have revealed some enticing information about how people develop immunity to malaria, opening the door to possible diagnostics and therapies. [ + ]
JW - bold in para 1 - sense? DB Award for Gamma Knife brain treatment
A major award to research a treatment for a dangerous and silent brain abnormality has been received.
[ + ]Final submissions for $100 million global challenge
GE is calling for final submissions for its $100 million global ‘healthymagination Challenge’ aimed at accelerating innovation in breast cancer, ahead of the closing date later this month.
[ + ]Joint venture saves Living Cell Technologies from closure
A 50/50 joint venture with Japanese Otsuka Pharmaceutical Factory has injected $25 million into the company which was running perilously short on cash. [ + ]
